72
Participants
Start Date
June 30, 2012
Primary Completion Date
December 31, 2013
Study Completion Date
December 31, 2013
Placebo matching with BMS-945429
Injection, Intravenous (IV), 0 mg, Day One Only, One Day
Placebo matching with BMS-945429
Injection, Subcutaneous (SC), 0 mg, Every 4 weeks, 8 weeks
Placebo matching with BMS-945429
Injection, Subcutaneous (SC), 0 mg, Week 4 Only, One Day
Placebo matching with BMS-945429
Injection, Subcutaneous (SC), 0 mg, Every 4 weeks, Up to 48 weeks
BMS-945429
Injection, Intravenous (IV), 600 mg, Day One Only, One Day
BMS-945429
Injection, Subcutaneous (SC), 200 mg, Week 8 only, One Day
BMS-945429
Injection, Intravenous (IV), 300 mg, Day One Only, One Day
BMS-945429
Injection, Subcutaneous (SC), 100 mg, Week 8 Only, One Day
BMS-945429
Injection, Subcutaneous (SC), 400 mg, Day One and Week 4, 4 weeks
BMS-945429
Injection, Intravenous (IV), 150 mg, Day One Only, One Day
BMS-945429
Injection, Subcutaneous (SC), 100 mg, Every 4 weeks, Up to 48 weeks
BMS-945429
Injection, Subcutaneous (SC), 200 mg, Every 4 weeks, Up to 48 weeks
BMS-945429
Injection, Subcutaneous (SC), 200 mg, Every 4 weeks, Up to 96 weeks, depending on when subject enters this period
Local Institution, Taipei
Local Institution, Vienna
Local Institution, Budapest
Local Institution, Debrecen
Local Institution, Pécs
Local Institution, Zurich
Premier Medical Group Of The Hudson Valley, Pc, Poughkeepsie
Local Institution, Mexico City
Local Institution, San Donato Milanese (mi)
Local Institution, Kiel
University Of Florida, Gainesville
Local Institution, Pessac
Local Institution, Padua
Gastro One, Germantown
Local Institution, Magdeburg
University Of Louisville, Louisville
Local Institution, Düsseldorf
Local Institution, Saint-Priest-en-Jarez
Local Institution, Herne
Local Institution, Münster
Local Institution, Hradec Králové
Local Institution, Florence
Local Institution, Lille
Local Institution, Frankfurt A. M
Local Institution, Clermont-Ferrand
Local Institution, Tel Aviv
Local Institution, Monterrey
Local Institution, San Giovanni Rotondo (fg)
Options Health Research, Llc, Tulsa
Local Institution, Rehovot
South Denver Gastroenterology, Pc, Lone Tree
Local Institution, Kaohsiung City
Local Institution, Jerusalem
University Of California, San Diego, La Jolla
Precision Research Institute, Llc, San Diego
Local Institution, Ludhiana
Local Institution, Mumbai
Local Institution, Pune
Local Institution, Hyderabad
Local Institution, Calgary
Local Institution, Vancouver
Local Institution, Saskatoon
Local Institution, Nice
Local Institution, Hong Kong
Local Institution, Mumbai
Local Institution, Roma
Local Institution, Nijmegen
Local Institution, Krakow
Local Institution, Lodz
Local Institution, Wroclaw
Local Institution, Wroclaw
Local Institution, Seoul
Local Institution, Seoul
Local Institution, Seoul
Local Institution, Hull
Local Institution, Harrow
Lead Sponsor
CSL Behring
INDUSTRY